Literature DB >> 9134165

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.

T Ruutu1, D Niederwieser, A Gratwohl, J F Apperley.   

Abstract

A survey was carried out among EBMT (European Group for Blood and Marrow Transplantation) centres of the practical details of the prophylaxis and treatment of acute GVHD. The emphasis was on the prophylactic use of cyclosporine A and methotrexate and their combination, and on the initial treatment of acute GVHD. Eighty-seven centres sent a report. This survey demonstrated that marked differences exist between centres in the practices of GVHD prophylaxis and treatment despite superficially similar protocols. These differences may have an impact on the results obtained.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9134165     DOI： 10.1038/sj.bmt.1700745

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  23 in total

Review 1.  Management of graft-versus-host disease in paediatric bone marrow transplant recipients.

Authors:  M Zecca; F Locatelli
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation.

Authors:  Tatsuo Furukawa; Tori Kurasaki-Ida; Masayoshi Masuko; Nobuhiro Tsukada; Kiyoshi Okazuka; Naoko Sato; Toshio Yano; Takashi Abe; Akihito Momoi; Yasuhiko Shibasaki; Masutaka Higashimura; Kaori Karimata; Masato Moriyama; Takashi Kuroha; Jun Takizawa; Ken Toba; Miwako Narita; Ichiro Fuse; Masuhiro Takahashi; Yoshifusa Aizawa
Journal:  Int J Hematol       Date:  2010-06-09       Impact factor: 2.490

3.  Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.

Authors:  T Ruutu; A Gratwohl; T de Witte; B Afanasyev; J Apperley; A Bacigalupo; F Dazzi; P Dreger; R Duarte; J Finke; L Garderet; H Greinix; E Holler; N Kröger; A Lawitschka; M Mohty; A Nagler; J Passweg; O Ringdén; G Socié; J Sierra; A Sureda; W Wiktor-Jedrzejczak; A Madrigal; D Niederwieser
Journal:  Bone Marrow Transplant       Date:  2013-07-29       Impact factor: 5.483

4.  Variation in management of immune suppression after allogeneic hematopoietic cell transplantation.

Authors:  Joseph Pidala; Stephanie J Lee; Gwen Quinn; Heather Jim; Jongphil Kim; Claudio Anasetti
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-11       Impact factor: 5.742

5.  Influence of dosing schedule on organ exposure to cyclosporin in pediatric hematopoietic stem cell transplantation: analysis with a PBPK model.

Authors:  Cécile Gérard; Nathalie Bleyzac; Pascal Girard; Gilles Freyer; Yves Bertrand; Michel Tod
Journal:  Pharm Res       Date:  2010-09-02       Impact factor: 4.200

6.  Links between cyclosporin exposure in tissues and graft-versus-host disease in pediatric bone marrow transplantation: analysis by a PBPK model.

Authors:  Cécile Gérard; Nathalie Bleyzac; Pascal Girard; Gilles Freyer; Yves Bertrand; Michel Tod
Journal:  Pharm Res       Date:  2010-10-21       Impact factor: 4.200

Review 7.  Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.

Authors:  David A Jacobsohn; Georgia B Vogelsang
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease.

Authors:  Céline Dartois; Gilles Freyer; Mauricette Michallet; Emilie Hénin; Benoît You; Isabelle Darlavoix; Claudine Vermot-Desroches; Brigitte Tranchand; Pascal Girard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

9.  Variation in supportive care practices in hematopoietic cell transplantation.

Authors:  Stephanie J Lee; Claudia C Astigarraga; Mary Eapen; Andrew S Artz; Stella M Davies; Richard Champlin; Madan Jagasia; Nancy A Kernan; Fausto R Loberiza; Margaret Bevans; Robert J Soiffer; Steven Joffe
Journal:  Biol Blood Marrow Transplant       Date:  2008-11       Impact factor: 5.742

Review 10.  Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I.

Authors:  Jeannine S McCune; Meagan J Bemer
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.